Fielder Capital Group’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$258K Sell
3,266
-84
-3% -$7.14K 0.06% 245
2026
Q1
$289K Buy
3,350
+70
+2% +$6.28K 0.06% 205
2025
Q4
$286K Buy
+3,280
New +$249K 0.06% 200
2025
Q1
Sell
-2,430
Closed -$201K 229
2024
Q4
$201K Buy
+2,430
New +$192K 0.06% 201

Other funds holding GMED

Fielder Capital Group's GMED Position: Q2 2026 in Review

Fielder Capital Group reduced its Globus Medical (GMED) stake by 2.5% in Q2 2026, selling an estimated $7.14K and leaving 3,266 shares worth $258K. The position accounts for 0.06% of the portfolio, ranked #245.

Fielder Capital Group first reported a position in GMED in Q4 2024 and has held it in 4 quarters since. The position peaked at $289K in Q1 2026. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Fielder Capital Group held 3,266 shares of Globus Medical worth $258K as of Q2 2026.
  • Fielder Capital Group sold 84 Globus Medical shares in Q2 2026, an estimated $7.14K.
  • Globus Medical made up 0.06% of Fielder Capital Group's portfolio in Q2 2026, its #245 holding.
  • Fielder Capital Group first reported a position in Globus Medical in Q4 2024 and has held it in 4 quarters since.
  • Fielder Capital Group's Globus Medical position peaked at $289K in Q1 2026.
  • 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Fielder Capital Group's 13F filing for Q2 2026, filed 6 Aug 2026.